TTOO Dividend: T2 Biosystems Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

TTOO Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Revenue	7	7	22	28	18	8
Revenue Growth (YoY)	-30%	-68%	-21%	56%	125%	-20%
Cost of Revenue	13	15	21	20	20	16
Gross Profit	-5	-8	1	7	-2	-8
Selling, General & Admin	22	24	30	28	20	27
Research & Development	12	13	24	21	16	16
Operating Expenses	35	38	56	50	37	43
Other Non Operating Income (Expenses)	1	5	0	0	0	0
Pretax Income	-42	-50	-62	-49	-46	-59
Income Tax Expense	--	--	--	--	--	--
Net Income	-42	-50	-62	-49	-46	-59
Net Income Growth	-14%	-19%	27%	7%	-22%	16%
Shares Outstanding (Diluted)	17.89	2.61	0.05	0.03	0.02	0.01
Shares Change (YoY)	300%	5,120%	67%	50%	100%	0%
EPS (Diluted)	-2.4	-19.18	-1,246.59	-1,641.33	-2,340	-5,901
EPS Growth	-78%	-98%	-24%	-30%	-60%	15%
Free Cash Flow	-36	-48	-50	-39	-44	-46
Free Cash Flow Per Share	-2.01	-18.39	-1,000	-1,300	-2,200	-4,600
Gross Margin	-71.42%	-114.28%	4.54%	25%	-11.11%	-100%
Operating Margin	-585.71%	-671.42%	-250%	-150%	-222.22%	-650%
Profit Margin	-600%	-714.28%	-281.81%	-175%	-255.55%	-737.5%
Free Cash Flow Margin	-514.28%	-685.71%	-227.27%	-139.28%	-244.44%	-575%
EBITDA	-41	-47	-54	-41	-39	-50
EBITDA Margin	-585.71%	-671.42%	-245.45%	-146.42%	-216.66%	-625%
D&A For EBITDA	0	0	1	1	1	2
EBIT	-41	-47	-55	-42	-40	-52
EBIT Margin	-585.71%	-671.42%	-250%	-150%	-222.22%	-650%
Effective Tax Rate	--	--	--	--	--	--